BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29297188)

  • 1. Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes.
    Bartuś K; Litwinowicz R; Kuśmierczyk M; Bilewska A; Bochenek M; Stąpór M; Woźniak S; Różański J; Sadowski J; Kapelak B
    Kardiol Pol; 2018; 76(3):618-624. PubMed ID: 29297188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis.
    Bartus K; Litwinowicz R; Bilewska A; Stapor M; Bochenek M; Rozanski J; Sadowski J; Filip G; Kusmierczyk M; Kapelak B
    Eur J Cardiothorac Surg; 2021 Jan; 59(2):434-441. PubMed ID: 33141188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissue.
    Johnston DR; Griffith BP; Puskas JD; Bavaria JE; Svensson LG;
    J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1478-1485. PubMed ID: 32340804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue.
    Puskas JD; Bavaria JE; Svensson LG; Blackstone EH; Griffith B; Gammie JS; Heimansohn DA; Sadowski J; Bartus K; Johnston DR; Rozanski J; Rosengart T; Girardi LN; Klodell CT; Mumtaz MA; Takayama H; Halkos M; Starnes V; Boateng P; Timek TA; Ryan W; Omer S; Smith CR;
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):432-439. PubMed ID: 28605428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and haemodynamic outcomes in 804 patients receiving the Freedom SOLO stentless aortic valve: results from an international prospective multicentre study.
    Grubitzsch H; Wang S; Matschke K; Glauber M; Heimansohn D; Tan E; Francois K; Thalmann M
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):e97-104. PubMed ID: 25501554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years.
    Riess FC; Cramer E; Hansen L; Schiffelers S; Wahl G; Wallrath J; Winkel S; Kremer P
    Eur J Cardiothorac Surg; 2010 Jan; 37(1):145-53. PubMed ID: 19695889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.
    Bavaria JE; Desai ND; Cheung A; Petracek MR; Groh MA; Borger MA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):590-7. PubMed ID: 23477687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years.
    Riess FC; Bader R; Cramer E; Hansen L; Kleijnen B; Wahl G; Wallrath J; Winkel S; Bleese N
    Ann Thorac Surg; 2007 Apr; 83(4):1310-8. PubMed ID: 17383332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-year durability of the aortic Hancock II bioprosthesis in young patients: is it durable enough?
    Une D; Ruel M; David TE
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):825-30. PubMed ID: 24510909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and mid-term outcomes after aortic valve replacement using a novel tissue bioprosthesis: a systematic review.
    Sef D; Thet MS; Klokocovnik T; Luthra S
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38331412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year Outcomes After Bicuspid Aortic Valve Replacement With a Novel Tissue Bioprosthesis.
    Bavaria JE; Mumtaz MA; Griffith B; Svensson LG; Pibarot P; Borger MA; Thourani VH; Blackstone EH; Puskas JD
    Ann Thorac Surg; 2024 Jul; 118(1):173-179. PubMed ID: 38135262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
    Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
    J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants.
    Johnston DR; Soltesz EG; Vakil N; Rajeswaran J; Roselli EE; Sabik JF; Smedira NG; Svensson LG; Lytle BW; Blackstone EH
    Ann Thorac Surg; 2015 Apr; 99(4):1239-47. PubMed ID: 25662439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
    McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
    Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A North American, prospective, multicenter assessment of the Mitroflow aortic pericardial prosthesis.
    Conte J; Weissman N; Dearani JA; Bavaria J; Heimansohn D; Dembitsky W; Doyle D
    Ann Thorac Surg; 2010 Jul; 90(1):144-152.e1-3. PubMed ID: 20609765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study.
    Englberger L; Carrel TP; Doss M; Sadowski J; Bartus K; Eckstein FF; Asch FM; Martens S
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1681-7. PubMed ID: 24787699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic valve replacement with a novel anti-calcification technology platform.
    Sadowski J; Bartuś K; Kapelak B; Chung A; Stąpor M; Bochenek M
    Kardiol Pol; 2015; 73(5):317-22. PubMed ID: 25371311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of bioprosthetic aortic valves in patients under the age of 60 years - rationale and design of the international INDURE registry.
    Meuris B; Borger MA; Bourguignon T; Siepe M; Grabenwöger M; Laufer G; Binder K; Polvani G; Stefano P; Coscioni E; van Leeuwen W; Demers P; Dagenais F; Canovas S; Theron A; Langanay T; Roussel JC; Wendler O; Mariscalco G; Pessotto R; Botta B; Bramlage P; de Paulis R
    J Cardiothorac Surg; 2020 May; 15(1):119. PubMed ID: 32460798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of pericardial versus porcine aortic valves.
    Gao G; Wu Y; Grunkemeier GL; Furnary AP; Starr A
    J Am Coll Cardiol; 2004 Jul; 44(2):384-8. PubMed ID: 15261935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.